Here are relevant reports on : vision-rehabilitation-devices-market
-
Vein Illuminator Market by Technology (Transillumination, Infrared Technology and Ultrasound), by End-Users (Hospitals, Rehabilitation Centers, Blood Donation Camps and Academic Institutions) - Global forecast to 2022
The vein illuminator market was valued at USD 32.2 Million in 2015 and is expected to reach USD 227.2 Million by 2022 at a CAGR of 32.41% between 2016 and 2022. The base year for analysis in this report is considered as 2015 and the forecast period is between 2016 and 2022. The market is segmented on the basis of technology, application, end users, and geography.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
Electrotherapy Market by Treatment Type (TSE, IC, PSWD, TENS, SCS, EA, PENS), Application (Sports Injury, Tissue Repair, Pain Management), By End User (Hospitals, Clinics, Rehabilitation Centres) - Global Forecast to 2022
The global electrotherapy market is expected to reach $1,076.1 Million by 2022 from $902.5 Million in 2017, growing at a CAGR of 4.0% from 2017 to 2022. Increasing incidences of diabetes; technological advancements in electrotherapy systems; increasing obesity; and rising number of sports injuries are some of the major driving factors driving the growth of the global electrotherapy market. However, lack of awareness about the usage of electrotherapy systems in developing countries; availability of large number of substitutes; and saturation in developed countries are hindering the growth of this market.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Home Healthcare Market by Product (Therapeutic, Testing, Screening, Monitoring, Mobility Care), Service (Nursing, Infusion Therapy, Rehabilitation, Palliative Care), Indication (Cancer, Diabetes, CVD, Respiratory, Wound Care) - Global Forecast to 2030
The global home healthcare market, valued at US$285.3 billion in 2024, stood at US$309.9 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$473.8 billion by the end of the period. This growth is driven by the rising elderly population, which is more prone to chronic conditions such as hypertension, diabetes, and cardiovascular diseases, increasing the need for ongoing care at home.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
North American Home Healthcare Market By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation Therapy] & Telehealth - Forecasts To 2017
The North America home health care market was valued at $90.9 billion in 2012; it is poised to grow at a CAGR of 7.5% to reach $130.4 billion by 2017. Home healthcare market includes products, services, and telehealth. The home care product category comprises homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, fitness, and nutrition products. Services include unskilled care, rehabilitation therapy, infusion therapy, and respiratory therapy, while telehealth includes home telehealth monitoring devices and telehealth services.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
European Home Healthcare Market By Products (Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit), Services (Respiratory Therapy, Rehabilitation Therapy) & Telehealth – Forecasts to 2017
The Europe home healthcare market is segmented as products, services, telehealth, and geography. The products market is further classified into homecare testing, screening & monitoring devices, home healthcare therapeutic equipment, mobility assist & other devices, and nutrition and fitness. The home healthcare services market is further segmented into unskilled care, rehabilitation therapy, infusion therapy and respiratory therapy, while the telehealth market includes monitoring devices, services, and managed equipment services. The total market is divided into seven major countries, i.e. Germany, France, U.K., Italy Spain, Russia, and Rest of Europe (RoE).
- Published: July 2013
- Price: $ 4950
- TOC Available:
-
Plywood Market by Type (Softwood, Hardwood), Application (Construction, Industrial), Use Type (New Construction, Rehabilitation), and Region - Global Forecast to 2030
The plywood market is expected to grow from USD 47.39 billion in 2024 to USD 60.31 billion by 2030, at a CAGR of 4.21% during the forecast period. The key players profiled in the report include Georgia-Pacific (US), Boise Cascade Company (US), Weyerhaeuser Company (US), UPM (Finland), SVEZA Group (Russia), Austral Plywoods (Australia), PotlatchDeltic Corporation (US), Greenply Industries Limited (India), Metsä Group (Finland), and CenturyPly (India).
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Vision Care Market - Forecast to 2023
The global vision care market is expected to reach approximately USD 64 Billion by 2023 from USD 52 Billion in 2018, at a CAGR of 4.2% from 2018 to 2023. The prominent players in the global vision care market are CooperVision (US), Essilor International S.A. (France), Carl Zeiss Meditec (Germany), Johnson & Johnson Vision Care (US), Luxottica (Italy), Novartis International AG (Switzerland), Valeant Pharmaceuticals (Canada), Bausch + Lomb (US), Menicon (Japan), and Paragon Vision Sciences (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Aircraft Synthetic Vision System Market (CA, Defence, Business Jet), By Products, Technology, Application & Geography - 2019
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Medical Device Reprocessing Market by Type (Reprocessed Medical Devices), Device Category (Critical- Devices, Semi-Critical Devices, Non-Critical Devices), Application (Cardiology, Gynecology, Gastroenterology, Anesthesia) - Global Forecast to 2027
The global medical device reprocessing market growth is primed to transition from USD 2.0 billion in 2022 to USD 3.9 billion by 2027, showcasing a strong CAGR of 13.7%. Growth in the market is mainly driven by the favorable regulatory standards for adoption of reprocessed medical devices by healthcare providers. On the other hand, the risk of infection from reprocessed medical devices may pose a threat to the market growth.
- Published: July 2022
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
